## Responsible AI Disclaimer

A responsible AI approach to a Next Best Action (NBA) solution in the pharmaceutical context requires careful attention to transparency, fairness, compliance, and appropriate use. Recommendations should be explainable in clear, business-relevant terms so that field teams understand the rationale and can apply their own judgment rather than follow outputs blindly. The system must avoid bias by ensuring that recommendations are not driven by inappropriate or sensitive attributes and that different HCP segments are treated equitably. Data used should be accurate, up to date, and compliant with privacy and regulatory standards, with no use of restricted or promotional-inappropriate signals. Importantly, NBA outputs should be framed as decision support—indicating likelihood of engagement rather than guaranteeing outcomes—so that they complement, rather than replace, human expertise. Regular monitoring, validation, and governance processes should be in place to ensure the model continues to perform as intended and aligns with evolving ethical and regulatory expectations.